Sanofi and Abbott Collaborate to Assimilate Glucose Sensing and Insulin Delivery Technologies to Manage Diabetes

 Sanofi and Abbott Collaborate to Assimilate Glucose Sensing and Insulin Delivery Technologies to Manage Diabetes

Sanofi and Abbott Collaborated to Assimilate Glucose Sensing and Insulin Delivery Technologies to Manage Diabetes

Shots:

  • Abbott and Sanofi team up to develop tools integrating their blood sugar tracking and insulin delivery technologies to help diabetes patients in managing their conditions
  • The non-exclusive agreement will combine Abbott’s FreeStyle Libre continuous glucose monitoring system with Sanofi’s connected insulin pens, apps and cloud software currently in development, allowing patients & doctors to share data and to make better treatment decisions around medication, nutrition and lifestyle
  • Abbott’s FreeStyle Libre system is used to monitor the glucose level via sensor and is linked with an app that enables users to capture real-time glucose levels, their eight-hour glucose history, and how their glucose is currently changing on their smartphones

Click here to­ read full press release/ article | Ref: Abbott | Image: Mediray

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post